NCT01025492View on ClinicalTrials.gov

Study of Trilipix Effects on Lipids and Arteries

PHASE4TerminatedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Dyslipidemia

Interventions

DRUG

Trilipix

135 mg po daily

DRUG

placebo

one tablet po daily

Trial Locations (1)

84108

University of Utah, Salt Lake City

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

University of Utah

OTHER